News
News-Medical.Net on MSN19h
Evolutionary mutation weakens human immune response to solid tumorsNew research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain ...
Anita Turk, MD, discusses abstracts from ASCO 2025 highlight the evolving role of ctDNA in the management of colorectal ...
Researchers at the University of California Davis Comprehensive Cancer Center have uncovered an evolutionary change that may ...
HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule ...
Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...
CytoDyn announces encouraging clinical findings among patients with advanced metastatic colorectal cancer previously treated with leronlimab: Vancouver, Washington Friday, July 4, ...
The Hearty Soul on MSN3h
Doctors Warn Just One Glass of This Drink a Day Could Increase Risk of Being Diagnosed With CancerCases of colon cancer have been on the rise for people under 50 years of age by 3% every year since 2011. According to the ...
AZoLifeSciences on MSN8h
Small Genetic Change in Humans Weakens Immune Attack on Solid TumorsNew research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain ...
The global snared devices market, valued at $950.2 million in 2021, is projected to reach $1,616.7 million by 2031, expanding at a CAGR of 5.2% from 2022 to 2031. Snared devices are specialized ...
Patients in a structured exercise program experienced a 37% lower risk of death and a 28% reduction in recurrence or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback